15-Hydroxy-eicosatetraenoic acid has minor anti-inflammatory properties in colitis

Agents Actions. 1993:38 Spec No:C120-1. doi: 10.1007/BF01991157.

Abstract

This study was performed to determine whether 15-HETE, which is the major metabolite of arachidonic acid (AA) in inflamed and normal human colonic tissue, has pro- or anti-inflammatory properties. To investigate these effects, 15-HETE (100 micrograms/kg/day) was administered rectally to mice with colitis induced by dextran sodium sulphate (DSS). Colons were removed and examined macroscopically and histologically and specimens were incubated with [14C]-AA and stimulated with A23187. Exogenous eicosanoids were separated by HPLC; the endogenously formed mediators were measured by radioimmunoassay. DSS produced a marked diffuse inflammatory response in the colon, associated with a raised inflammation score (mean 7.6 vs. < 0.5) and a significant increase in endogenously formed metabolites PGE2, LTB4 and 12-HETE. 15-HETE treatment resulted in a slight decrease in inflammation score (6.4 vs. 7.6) and a slight, but not significant, decrease in endogenous LTB4.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Colitis / chemically induced
  • Colitis / drug therapy*
  • Colitis / physiopathology
  • Dextran Sulfate
  • Eicosanoids / biosynthesis
  • Female
  • Hydroxyeicosatetraenoic Acids / therapeutic use*
  • Mice
  • Mice, Inbred BALB C

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Eicosanoids
  • Hydroxyeicosatetraenoic Acids
  • 15-hydroxy-5,8,11,13-eicosatetraenoic acid
  • Dextran Sulfate